ArticleCurrent oncology (Toronto, Ont.)2025

Outcomes of Allogeneic Stem Cell Transplant in Patients with Relapsed/Refractory Hodgkin Lymphoma.

Shiliang Ge et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.